In today’s recent session, 1.26 million shares of the Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) have been traded, and its beta is -0.16. Most recently the company’s share price was $1.85, and it changed around $0.05 or 2.78% from the last close, which brings the market valuation of the company to $4.16M. LIXT at last check was trading at a discount to its 52-week high of $4.42, offering almost -138.92% off that amount. The share price’s 52-week low was $1.58, which indicates that the recent value has risen by an impressive 14.59% since then. We note from Lixte Biotechnology Holdings Inc’s average daily trading volume that its 10-day average is 10440.0 shares, with the 3-month average coming to 33.25K.
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) trade information
Instantly LIXT has been showing a green trend so far today with a performance of 2.78% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.1000 on recent trading dayincreased the stock’s daily price by 11.9%. The company’s shares are currently down -21.28% year-to-date, but still down -8.03% over the last five days. On the other hand, Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) is -22.92% down in the 30-day period. We can see from the shorts that 8024.0 shares have been sold at a short interest cover period of 1.31 day(s).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
LIXT Dividends
Lixte Biotechnology Holdings Inc’s next quarterly earnings report is expected to be released in September.
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 20.48% of Lixte Biotechnology Holdings Inc shares, and 7.93% of them are in the hands of institutional investors. The stock currently has a share float of 9.97%.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 7.35 shares worth $13086.0, making up 0.33% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 5.21 shares worth around $9272.0, which represents about 0.23% of the total shares outstanding.
